IP
Intellectus Partners’s Intellia Therapeutics NTLA Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $806K | Buy |
85,975
+3,150
| +4% | +$29.5K | 0.17% | 147 |
|
|
2025
Q1 | $589K | Buy |
82,825
+8,300
| +11% | +$59K | 0.15% | 171 |
|
|
2024
Q4 | $869K | Buy |
74,525
+15,700
| +27% | +$183K | 0.19% | 143 |
|
|
2024
Q3 | $1.21M | Buy |
58,825
+600
| +1% | +$12.3K | 0.31% | 97 |
|
|
2024
Q2 | $1.3M | Buy |
58,225
+1,225
| +2% | +$27.4K | 0.36% | 77 |
|
|
2024
Q1 | $1.57M | Buy |
57,000
+1,350
| +2% | +$37.1K | 0.41% | 70 |
|
|
2023
Q4 | $1.7M | Buy |
55,650
+4,900
| +10% | +$149K | 0.49% | 59 |
|
|
2023
Q3 | $1.6M | Sell |
50,750
-650
| -1% | -$20.6K | 0.51% | 53 |
|
|
2023
Q2 | $2.1M | Buy |
51,400
+5,135
| +11% | +$209K | 0.63% | 40 |
|
|
2023
Q1 | $1.72M | Buy |
46,265
+600
| +1% | +$22.4K | 0.54% | 51 |
|
|
2022
Q4 | $1.59M | Buy |
45,665
+3,700
| +9% | +$129K | 0.55% | 53 |
|
|
2022
Q3 | $2.35M | Sell |
41,965
-1,260
| -3% | -$70.5K | 0.84% | 29 |
|
|
2022
Q2 | $2.24M | Sell |
43,225
-1,225
| -3% | -$63.4K | 0.77% | 29 |
|
|
2022
Q1 | $3.23M | Sell |
44,450
-3,075
| -6% | -$223K | 0.96% | 19 |
|
|
2021
Q4 | $5.62M | Sell |
47,525
-3,425
| -7% | -$405K | 1.43% | 11 |
|
|
2021
Q3 | $6.84M | Buy |
50,950
+2,300
| +5% | +$309K | 1.65% | 9 |
|
|
2021
Q2 | $7.88M | Sell |
48,650
-22,975
| -32% | -$3.72M | 1.78% | 8 |
|
|
2021
Q1 | $4.61M | Buy |
71,625
+5,700
| +9% | +$367K | 1.27% | 13 |
|
|
2020
Q4 | $3.59M | Buy |
65,925
+20,275
| +44% | +$1.1M | 1.07% | 18 |
|
|
2020
Q3 | $908K | Buy |
+45,650
| New | +$908K | 0.34% | 88 |
|